Developer docs
API playgroundTry for free, no card

Search company profiles

iotaMotion

Full company profile

uuid0000lrl

Namestring
iotaMotion
Legal namestring
iotaMotion, Inc.
Websiteurl
iotamotion.com
Company typeenum
Private
Founded yearint
2015
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSaint Paul, United States
HQ citystring
Saint Paul
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
robotic-assisted surgery, cochlear implant devices, surgical robotics systems, ENT medical technology, hearing preservation technology
Industry1 code
PRIMARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Cochlear Implant Surgical Robotics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1iotaSOFT Insertion System Sales
TypeHardware Sales
Description

Sale of the iotaSOFT Robotic-Assisted Cochlear Implant Insertion System to hospitals and cochlear implant centers. The system includes a bone-mounted drive unit and reusable console with foot pedal control.

iotamotion.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain, Infrastructure
Pricing details1 tier
1Enterprise/hospital sales - custom pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is determined through direct consultation with iotaMotion's sales team. No public pricing available.

iotamotion.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1iotaSOFT
Description

iotaSOFT Insertion System - The first and only FDA-cleared robotic-assisted cochlear implant insertion system that provides controlled electrode array insertion at speeds beyond human capabilities.

iotamotion.com
Core offering1 text field

iotaMotion develops and sells the iotaSOFT Insertion System, a robotic-assisted system used by surgeons during cochlear implant surgery to control the speed of electrode array insertion. The system consists of a thumb-sized bone-mounted drive unit and a reusable console with foot pedal control, designed as an open platform compatible with multiple cochlear implant manufacturers. It is sold to hospitals and cochlear implant centers as a capital equipment purchase to standardize electrode insertion and reduce insertion trauma.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 51% reduction in maximum insertion force compared to manual insertion
+4 more records
Product overview1 text field

iotaMotion is a single-product medical technology company offering the iotaSOFT Insertion System, the first and only FDA-cleared robotic-assisted cochlear implant insertion system commercially available in the United States. The system is an open platform designed to work with surgeons during the critical electrode array insertion phase of cochlear implant surgery, controlling insertion speed to reduce force variability and trauma. The technology standardizes one of the most delicate steps in cochlear implantation, enabling slow and consistent electrode advancement that preserves intracochlear structures.

Product and service1 record
1iotaSOFT Insertion System
CategoryRobotic-Assisted Cochlear Implant Insertion System
Description

The iotaSOFT Insertion System is a robotic-assisted cochlear implant insertion device consisting of a thumb-sized bone-mounted drive unit and a reusable console with foot pedal control. It provides slow and consistent electrode array insertion at speeds beyond human capability, reducing maximum insertion force by 51% and insertion force variation by 78% compared to manual insertion. It is an open platform compatible with multiple cochlear implant manufacturers and is FDA cleared for patients 4 years and older. Sold to hospitals, academic medical centers, and cochlear implant centers for use by ENT surgeons during cochlear implant procedures.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-14
Description

First dedicated pediatric center to adopt iotaSOFT following FDA clearance for expanded pediatric use (ages 4+). Nationally ranked pediatric medical center and U.S. News & World Report Honor Roll member for 2025-2026.

2University Hospital of Zurich
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-13
Description

First international clinical investigation site for iotaSOFT outside the United States, led by Professor Alexander Huber. Study titled 'Analysis of electrocochleographic signals during speed-controlled cochlear implant electrode array insertion'.

iotamotion.com
Strategic tierMinorTypeGTM or Marketing Partner
Description

Partnership for continuing education (CEU) courses for audiologists, helping to educate hearing professionals about iotaSOFT technology and robotic-assisted cochlear implantation.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

MED-EL is a privately held cochlear implant manufacturer based in Austria with a global footprint. iotaSOFT's open-platform design is compatible with MED-EL electrode arrays, positioning MED-EL as a complementary partner serving the same surgical workflow that iotaMotion enables.

TypeBroad incumbent
Description

Intuitive Surgical dominates surgical robotics with the da Vinci platform. While it does not currently compete in cochlear insertion, its scale, R&D capacity, and hospital relationships make it a potential long-term entrant into ENT or other subspecialty robotic insertion.

TypeBroad incumbent
Description

Cochlear Limited is the world's largest cochlear implant manufacturer and a complementary counterpart to iotaMotion. While iotaMotion sells the robotic insertion system, Cochlear sells the implant and electrode array that iotaSOFT inserts. Their compatibility creates a partnership dynamic in the surgical workflow.

4THINK Surgical
TypeDirect peer
Description

THINK Surgical develops robotic systems for orthopedic surgery, similar in scale and stage to iotaMotion. Both companies are independent surgical robotics firms commercializing procedure-specific robotic platforms with FDA clearances, comparable capital equipment sales motions, and similar customer profiles (academic hospitals).

TypeEmerging player
Description

Moon Surgical is a venture-backed surgical robotics company developing a laparoscopic surgical assist platform with a small footprint similar in design philosophy to iotaSOFT. Comparable in stage and go-to-market approach (enterprise sales to academic hospitals), though in a different surgical specialty.

TypeBroad incumbent
Description

Stryker's Mako robotic system is the dominant orthopedic surgical robotics platform. As a broad incumbent with deep hospital capital relationships and Mike Lobinsky's prior tenure, Stryker represents a potential large-player threat that could choose to extend into ENT surgical robotics.

7Galen Robotics
TypeEmerging player
Description

Galen Robotics is an early-stage company developing collaborative robotic assistance for ENT and other microsurgical procedures. It overlaps with iotaMotion's clinical niche (ENT surgical robotics) but focuses on different sub-procedures, making it the closest emerging peer in robotic-assisted ENT surgery.

TypeEmerging player
Description

Vicarious Surgical is a publicly-traded, venture-backed surgical robotics company developing a combined robotics and VR platform for minimally invasive surgery. Comparable in stage-of-life (commercializing a novel robotic platform) but serves general/abdominal surgery rather than cochlear insertion.

TypeBroad incumbent
Description

Smith & Nephew acquired Blue Belt Technologies (where iotaMotion CEO Mike Lobinsky and CTO Costa Nikou previously worked) for surgical robotics in orthopedics. As a broad incumbent in surgical robotics with deep ENT ties via Smith & Nephew ENT, it represents a potential competitor that could leverage scale to enter cochlear insertion robotics.

TypeBroad incumbent
Description

Advanced Bionics, owned by Sonova, is one of the major cochlear implant manufacturers globally. Like Cochlear Limited, it is complementary to iotaMotion because iotaSOFT is an open platform compatible with its electrode arrays, making them channel partners rather than direct competitors.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds11 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

iotaMotion

Cochlear Implant Surgical Roboticsiotamotion.com

iotaMotion firmographics

Firmographics
Name
iotaMotion
Legal name
iotaMotion, Inc.
Website
https://iotamotion.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

iotaMotion industry classification

Industry
Product category
Cochlear Implant Surgical Robotics
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • Robotic-assisted surgery
  • Cochlear implant devices
  • Surgical robotics systems
  • ENT medical technology
  • Hearing preservation technology

Where iotaMotion is headquartered

Location

Headquarters

HQ city
Saint Paul
HQ country
United States
HQ region
North America

Offices2 records

Markets served

iotaMotion business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain, Infrastructure

Revenue model

  1. iotaSOFT Insertion System Sales: Sale of the iotaSOFT Robotic-Assisted Cochlear Implant Insertion System to hospitals and cochlear implant centers. The system includes a bone-mounted drive unit and reusable console with foot pedal control.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise/hospital sales - custom pricing

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

iotaMotion product offering

Product offering

Core offering

iotaMotion develops and sells the iotaSOFT Insertion System, a robotic-assisted system used by surgeons during cochlear implant surgery to control the speed of electrode array insertion. The system consists of a thumb-sized bone-mounted drive unit and a reusable console with foot pedal control, designed as an open platform compatible with multiple cochlear implant manufacturers. It is sold to hospitals and cochlear implant centers as a capital equipment purchase to standardize electrode insertion and reduce insertion trauma.

Product overview

iotaMotion is a single-product medical technology company offering the iotaSOFT Insertion System, the first and only FDA-cleared robotic-assisted cochlear implant insertion system commercially available in the United States. The system is an open platform designed to work with surgeons during the critical electrode array insertion phase of cochlear implant surgery, controlling insertion speed to reduce force variability and trauma. The technology standardizes one of the most delicate steps in cochlear implantation, enabling slow and consistent electrode advancement that preserves intracochlear structures.

Differentiator

Problem solved

Functional benefit

Brands

  • iotaSOFT: iotaSOFT Insertion System - The first and only FDA-cleared robotic-assisted cochlear implant insertion system that provides controlled electrode array insertion at speeds beyond human capabilities.

Products and services

  • iotaSOFT Insertion System The iotaSOFT Insertion System is a robotic-assisted cochlear implant insertion device consisting of a thumb-sized bone-mounted drive unit and a reusable console with foot pedal control. It provides slow and consistent electrode array insertion at speeds beyond human capability, reducing maximum insertion force by 51% and insertion force variation by 78% compared to manual insertion. It is an open platform compatible with multiple cochlear implant manufacturers and is FDA cleared for patients 4 years and older. Sold to hospitals, academic medical centers, and cochlear implant centers for use by ENT surgeons during cochlear implant procedures.

Quantifiable outcome

  • 51% reduction in maximum insertion force compared to manual insertion
  • +4 more outcomes

Companies that use iotaMotion

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles2 records

iotaMotion technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

iotaMotion partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Cincinnati Children's HospitalcoreStrategic or Co-development Partner · 14 January 2026First dedicated pediatric center to adopt iotaSOFT following FDA clearance for expanded pediatric use (ages 4+). Nationally ranked pediatric medical center and U.S. News & World Report Honor Roll member for 2025-2026.
  • University Hospital of ZurichcoreStrategic or Co-development Partner · 13 May 2025First international clinical investigation site for iotaSOFT outside the United States, led by Professor Alexander Huber. Study titled 'Analysis of electrocochleographic signals during speed-controlled cochlear implant electrode array insertion'.
  • AudiologyOnlineminorGTM or Marketing PartnerPartnership for continuing education (CEU) courses for audiologists, helping to educate hearing professionals about iotaSOFT technology and robotic-assisted cochlear implantation.

Scale indicators10 records

Recent moves9 records

Expansion highlights6 records

iotaMotion competitors and assessment

Company assessment

Broad incumbents

  • MED-EL: MED-EL is a privately held cochlear implant manufacturer based in Austria with a global footprint. iotaSOFT's open-platform design is compatible with MED-EL electrode arrays, positioning MED-EL as a complementary partner serving the same surgical workflow that iotaMotion enables.
  • Intuitive Surgical: Intuitive Surgical dominates surgical robotics with the da Vinci platform. While it does not currently compete in cochlear insertion, its scale, R&D capacity, and hospital relationships make it a potential long-term entrant into ENT or other subspecialty robotic insertion.
  • Cochlear Limited: Cochlear Limited is the world's largest cochlear implant manufacturer and a complementary counterpart to iotaMotion. While iotaMotion sells the robotic insertion system, Cochlear sells the implant and electrode array that iotaSOFT inserts. Their compatibility creates a partnership dynamic in the surgical workflow.
  • Stryker (Mako Robotics): Stryker's Mako robotic system is the dominant orthopedic surgical robotics platform. As a broad incumbent with deep hospital capital relationships and Mike Lobinsky's prior tenure, Stryker represents a potential large-player threat that could choose to extend into ENT surgical robotics.
  • Smith & Nephew (Surgical Robotics): Smith & Nephew acquired Blue Belt Technologies (where iotaMotion CEO Mike Lobinsky and CTO Costa Nikou previously worked) for surgical robotics in orthopedics. As a broad incumbent in surgical robotics with deep ENT ties via Smith & Nephew ENT, it represents a potential competitor that could leverage scale to enter cochlear insertion robotics.
  • Advanced Bionics (Sonova): Advanced Bionics, owned by Sonova, is one of the major cochlear implant manufacturers globally. Like Cochlear Limited, it is complementary to iotaMotion because iotaSOFT is an open platform compatible with its electrode arrays, making them channel partners rather than direct competitors.

Direct peers

  • THINK Surgical: THINK Surgical develops robotic systems for orthopedic surgery, similar in scale and stage to iotaMotion. Both companies are independent surgical robotics firms commercializing procedure-specific robotic platforms with FDA clearances, comparable capital equipment sales motions, and similar customer profiles (academic hospitals).

Emerging players

  • Moon Surgical: Moon Surgical is a venture-backed surgical robotics company developing a laparoscopic surgical assist platform with a small footprint similar in design philosophy to iotaSOFT. Comparable in stage and go-to-market approach (enterprise sales to academic hospitals), though in a different surgical specialty.
  • Galen Robotics: Galen Robotics is an early-stage company developing collaborative robotic assistance for ENT and other microsurgical procedures. It overlaps with iotaMotion's clinical niche (ENT surgical robotics) but focuses on different sub-procedures, making it the closest emerging peer in robotic-assisted ENT surgery.
  • Vicarious Surgical: Vicarious Surgical is a publicly-traded, venture-backed surgical robotics company developing a combined robotics and VR platform for minimally invasive surgery. Comparable in stage-of-life (commercializing a novel robotic platform) but serves general/abdominal surgery rather than cochlear insertion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

iotaMotion social profiles

Digital presence

iotaMotion financial estimates

Financial estimate

Revenue estimate

Valuation estimate

iotaMotion leadership team

Management profile

Number of profiles

Profiles14 records

iotaMotion funding detail

Funding detail

Funding overview

Funding rounds11 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

iotaMotion M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iotaMotion

What does iotaMotion do?

iotaMotion develops and sells the iotaSOFT Insertion System, a robotic-assisted system used by surgeons during cochlear implant surgery to control the speed of electrode array insertion. The system consists of a thumb-sized bone-mounted drive unit and a reusable console with foot pedal control, designed as an open platform compatible with multiple cochlear implant manufacturers. It is sold to hospitals and cochlear implant centers as a capital equipment purchase to standardize electrode insertion and reduce insertion trauma.

Is iotaMotion a public or private company?

iotaMotion is a private company. It is classified as venture growth investor backed and is currently operating.

When was iotaMotion founded?

iotaMotion was founded in 2015. It employs 11 to 50 people.

Where is iotaMotion based?

iotaMotion is headquartered in Saint Paul, United States, in the North America region.

How does iotaMotion make money?

One revenue line is on record: iotaSOFT Insertion System Sales.

Who are iotaMotion's main competitors?

Broad incumbents on record are MED-EL, Intuitive Surgical, Cochlear Limited, Stryker (Mako Robotics), Smith & Nephew (Surgical Robotics) and Advanced Bionics (Sonova). THINK Surgical is listed as a direct peer. Emerging players are Moon Surgical, Galen Robotics and Vicarious Surgical.

Does iotaMotion have an API?

No public API is recorded for iotaMotion.

What industry is iotaMotion in?

iotaMotion's product category is Cochlear Implant Surgical Robotics. Its primary akta.pro industry code is HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireIotaMotion renforce sa position de leader dans le domaine de la chirurgie robotique des prothèses cochléaires avec l'obtention d'un nouveau brevet américainiotaMotion, Inc. has been granted US Patent No. 12,558,123, strengthening its intellectual property portfolio in robotic-assisted cochlear implant surgery technology. The company's flagship iotaSOFT system, the first and only FDA-authorized robotic-assisted cochlear implant insertion system, enables controlled electrode insertion to preserve delicate intracochlear structures for patients four years and older. CEO Mike Lobinsky stated that IP protection is essential for maintaining leadership as the technology becomes increasingly integrated into major cochlear implant centers.PR NewswireIotaMotion Strengthens Leadership Position in Robotic Cochlear Implant Surgery with Issuance of New U.S. PatentiotaMotion, Inc. announced the issuance of U.S. Patent No. 12,558,123, strengthening its intellectual property portfolio in robotic-assisted cochlear implantation for its iotaSOFT system. The iotaSOFT Robotic-Assisted Cochlear Implant Insertion System is the first and only FDA-cleared robotic-assisted cochlear implant insertion system, commercially available in the United States for patients four years and older. The company stated that protecting these technologies is central to sustaining its leadership as robotic-assisted technology gains clinical adoption at leading cochlear implant centers.PR NewswireIotaMotion Strengthens Leadership Position in Robotic Cochlear Implant Surgery with Issuance of New U.S. PatentiotaMotion, Inc., a St. Paul, Minnesota-based medical technology company, announced the issuance of U.S. Patent No. 12,558,123 covering systems and methods for robotic positioning and control in cochlear implant surgery, expanding its intellectual property portfolio around the iotaSOFT system. The patent issuance comes as the FDA-cleared robotic-assisted cochlear implant insertion system gains adoption across leading cochlear implant centers in the United States. With fewer than 5% of the 60 million people worldwide who could benefit from cochlear implants currently receiving them, iotaMotion positioned the IP protection as central to sustaining leadership in the field.PR NewswireIotaMotion stärkt seine Führungsposition im Bereich der robotergestützten Cochlea-Implantat-Chirurgie durch die Erteilung eines neuen US-PatentsiotaMotion, a medical device company based in St. Paul, Minnesota, has been granted US Patent No. 12.558.123, expanding its intellectual property portfolio covering robotic positioning and control systems for cochlear implant surgery. The patent strengthens protection for iotaSOFT, the company's FDA-cleared robotic-assisted cochlear implant insertion system, which enables slow, consistent electrode insertion to preserve delicate intracochlear structures. CEO Mike Lobinsky stated that protecting these technologies is central to maintaining the company's leadership position as the system gains adoption in leading cochlear implant centers.PR NewswireIotaMotion refuerza su liderazgo en la cirugía robótica de implantes coclearesiotaMotion, Inc. announced the issuance of US Patent No. 12,558,123, strengthening its intellectual property portfolio in robotic-assisted cochlear implant surgery. The patent covers systems and methods related to robotic positioning and control in cochlear implant procedures, supporting the company's market leadership position. The iotaSOFT Robotic-Assisted Cochlear Implant Insertion System remains the first and only FDA-cleared robotic-assisted cochlear implant insertion system, approved for patients four years and older, with fewer than 5% of the 60 million eligible patients worldwide currently receiving implants.BioSpaceIotaMotion Strengthens Leadership Position in Robotic Cochlear Implant Surgery with Issuance of New U.S. PatentiotaMotion, Inc. announced the issuance of U.S. Patent No. 12,558,123, strengthening its intellectual property portfolio in robotic-assisted cochlear implantation surgery. The patent covers systems and methods related to robotic positioning and control in cochlear implant procedures, supporting the company's iotaSOFT system, which is the first and only FDA-cleared robotic-assisted cochlear implant insertion system available in the United States for patients four years of age and older.MorningstarIotaMotion Strengthens Leadership Position in Robotic Cochlear Implant Surgery with Issuance of New U.S. PatentiotaMotion, Inc. announced the issuance of U.S. Patent No. 12,558,123, strengthening its intellectual property portfolio in robotic-assisted cochlear implantation for its iotaSOFT system. The patent covers systems and methods related to robotic positioning and control in cochlear implant surgery, protecting technologies that standardize and control electrode insertion as adoption expands across leading implant centers. The FDA-cleared iotaSOFT system is the first and only robotic-assisted cochlear implant insertion system commercially available in the United States for patients four years of age and older.Investing.comFDA clears iotaMotion’s cochlear implant system for children from age four By Investing.comOrthoPediatrics Corp. partner iotaMotion received FDA 510(k) clearance for expanded pediatric use of its iotaSOFT Insertion System, allowing robotic-assisted cochlear implant electrode array insertion for children aged four and older. Cincinnati Children's Hospital has become the first dedicated pediatric center to adopt the technology, joining over 35 cochlear implant centers across the United States. The milestone represents a strategic advancement for OrthoPediatrics' Enabling Technologies division as it expands beyond orthopedics into adjacent areas of pediatric care.GlobeNewswireOrthoPediatrics Announces Expanded Enabling Technology Market OpportunityOrthoPediatrics announced that iotaMotion's iotaSOFT Insertion System received FDA 510(k) clearance for expanded pediatric use in children four years and older. The system is the first FDA-authorized open platform robotic-assisted technology for cochlear implant electrode insertion. Cincinnati Children's Hospital became the first pediatric center to adopt it.TipranksOrthoPediatrics announces iotaMotion received FDA 510k clearance for iotaSOFTOrthoPediatrics announced that its partner iotaMotion received FDA 510(k) clearance for expanded pediatric use of its iotaSOFT Insertion System. The system is now cleared for use in patients four years of age and older, extending access to robotic-assisted cochlear implantation for school-aged children. The CEO commented that this milestone allows the company to leverage existing capabilities and bring pediatric-first expertise beyond orthopedics into the ENT space.